Keywords: Insulin biosimilars, Marvel LifeSciences, EMA, MAA withdrawal

Marvel LifeSciences drops EU application for three human insulin biosimilars

Article | 27 November 2012

Print This

The European Medicines Agency said yesterday that it has been formally notified by UK-based Marvel LifeScience Ltd of its decision ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in